Nkure Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 05-11-2024
- Paid Up Capital ₹ 2.54 Cr
as on 05-11-2024
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
About Nkure Therapeutics
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.54 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lalitkumar Pai, Ashok Vohra, and Mahendra Rao serve as directors at the Company.
- CIN/LLPIN
U73100KA2022PTC157838
- Company No.
157838
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nkure Therapeutics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Vohra  | Director | 11-Feb-2022 | Current |
Lalitkumar Pai  | Director | 01-Aug-2023 | Current |
Mahendra Rao  | Director | 04-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Nkure Therapeutics.
Nkure Therapeutics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nkure Therapeutics?
In 2023, Nkure Therapeutics had a public holding of 84.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Escape Velocity Accelerator India Private LimitedActive 10 years 10 monthsAshok Vohra is a mutual person
Eyestem Research Private LimitedActive 9 years 3 monthsAshok Vohra and Mahendra Rao are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nkure Therapeutics?
Nkure Therapeutics has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nkure Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nkure Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
